The COL17A1 gene gives your body instructions for making collagen XVII, a protein that helps anchor the top layer of skin to the layers beneath it. If this gene does not work properly, the skin can become fragile and blister easily, sometimes along with nail, tooth, hair, or eye problems. This gene plays an important role in keeping skin and some other body surfaces strong during everyday rubbing and movement. Changes in the COL17A1 gene are best known for causing some forms of epidermolysis bullosa, an inherited skin condition.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do the work. Others mainly help direct when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. More in depth information on this topic is available in the LearnHub.
Overview
COL17A1Gene function
What if the gene works
The COL17A1 gene helps make a protein that anchors the outer skin layer to deeper tissue. This support helps skin stay strong during everyday rubbing and movement. It also plays a part in hair follicles.
Risk
What if the gene does not work
Variants in the COL17A1 gene most often cause junctional epidermolysis bullosa, a condition with very fragile skin, blistering, nail changes, and sometimes hair or tooth problems. Milder to more severe variants can affect when symptoms begin and how widespread they are.
Treatment
What does that mean for your treatment
No COL17A1-specific treatment or drug selection is currently established in clinical guidelines for pathogenic variants in the COL17A1 gene. Care is based on symptoms, while experimental gene and cell based approaches for COL17A1-related skin fragility conditions are under study but are not standard treatment.
Conditions associated with COL17A1
Gene function
What if the gene works
Your skin handles constant rubbing, stretching, and washing. The COL17A1 gene helps the outer skin layer stay attached to the layer underneath, especially in places that face daily friction. Its protein is part of tiny anchoring structures that keep surface cells steady.
The COL17A1 gene helps anchor surface skin cells to the support layer below. This is a key part of how the skin layers stay attached during everyday movement and contact.
Its protein sits across the cell surface and links inner support fibers to the material outside the cell. These links help skin cells stay firmly in place.
By strengthening these anchor points, the COL17A1 gene supports a stable skin surface. This helps the skin act as a more reliable protective barrier in daily life.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the COL17A1 gene can change the shape of collagen XVII, reduce how much reaches the cell surface, or stop the protein from being made at all. This helps explain how COL17A1 gene variants affect skin anchoring at a microscopic level. Some variants leave partial activity and are often linked to milder disease, while more disruptive variants can cause little or no working protein and may lead to earlier or more marked features of junctional epidermolysis bullosa.
How variants are linked to conditions
Pathogenic variants in the COL17A1 gene cause some forms of junctional epidermolysis bullosa, including localized and intermediate types, so COL17A1 gene variants linked to skin blistering conditions are a well-established finding in medical genetics. Some variants in the COL17A1 gene are also linked to epithelial recurrent erosion dystrophy, an inherited eye condition affecting the cornea.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For COL17A1, risk is mainly shaped by whether a disease-causing change in the gene is inherited, so lifestyle factors are not known to strongly change the chance of having the related condition. Friction, skin injury, and similar triggers can make symptoms worse in people living with a COL17A1-related condition, but there is not enough evidence to say they change the underlying genetic risk.
Inheritance of COL17A1 variants
Variants in the COL17A1 gene can be inherited in different ways, depending on the condition they cause. COL17A1-related junctional epidermolysis bullosa is usually inherited in an autosomal recessive pattern, which means a child inherits one nonworking copy from each parent; when both parents are carriers, each pregnancy has a 25% chance of being affected. Some other COL17A1-related conditions, including certain corneal conditions, follow an autosomal dominant pattern, so a parent carrying the variant can pass it on to each child with a 50% chance.
What does my COL17A1 result mean for my family?
For families with a disease-causing change in the COL17A1 gene, the condition is usually passed down in a recessive way, which means close relatives may also be carriers even if they have no symptoms. Brothers and sisters may be affected or may carry the same gene change. Other relatives on both sides of the family can sometimes carry it too, so a family result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
COL17A1 genetic testing usually uses a blood or saliva sample. A lab reads the DNA sequence to look for variants in the COL17A1 gene, often as part of an inherited skin condition panel or a broader exome test. Results can show whether a disease-causing variant is found, not found, or remains uncertain.
When should I consider getting a genetic test?
Consider genetic testing for the COL17A1 gene if someone has very fragile skin with blistering or open sores after minor rubbing, especially from birth or early childhood, or if this runs in the family. Testing can help confirm an inherited skin condition linked to COL17A1 and clarify the chance of it affecting other relatives.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the kind of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences affect the way people respond to medications. It examines relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can help support treatment decisions that are more informed and more personalized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the COL17A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response, so general health concerns or questions about medicines are best discussed with your doctor.
History
The COL17A1 gene entered medical research through studies of blistering skin conditions in the late 20th century. Initially understood only through visible traits, later recognized as tied to a specific gene, this work connected an important skin protein known as BP180 to inherited forms of epidermolysis bullosa. In the 1990s, researchers identified disease causing variants in the COL17A1 gene in people with junctional epidermolysis bullosa, helping explain why some families had skin that blistered so easily from birth. Around the same time, laboratory studies linked the same protein to bullous pemphigoid, an autoimmune skin condition. From these first observations, research expanded steadily. This history made the COL17A1 gene an important bridge between inherited skin conditions and immune related blistering disease.